- Release of [OncoKB™ SOP v5.2](https://www.oncokb.org/sop)
- OncoTree updated from version [2019_12_01](https://oncotree.info/?version=oncotree_2019_12_01&field=NAME) to version oncotree_latest_stable, which incorporates changes to the CNS branch of OncoTree
- Transcripts have been updated for the following genes to better align with coordinating resources: ATXN7, CCNQ, CDKN2A, CRLF2, GAB1, KBTBD4, MUTYH, NADK, PAX8, PGBD5, RBM10
- CDKN2A has been split into the p16 and p14 isoforms

**Updated Therapeutic Implications**

- New alteration(s) with a tumor type-specific level of evidence

| Level | Gene  | Mutation | Cancer Type                            | Drug(s) Added to OncoKB™ | Evidence                                                                                                                                                                                                                        |
| :---- | :---- | :------- | :------------------------------------- | :----------------------- | :------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ |
| 1     | H3-3A | K28M     | Diffuse Midline Glioma, H3 K27-Altered | Dordaviprone (Level 1\)  | [FDA approval of dordaviprone](https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-dordaviprone-diffuse-midline-glioma); PMID: [38335473](https://pubmed.ncbi.nlm.nih.gov/38335473/) |
| 1     | H3C2  | K28M     | Diffuse Midline Glioma, H3 K27-Altered | Dordaviprone (Level 1\)  | [FDA approval of dordaviprone](https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-dordaviprone-diffuse-midline-glioma); PMID: [38335473](https://pubmed.ncbi.nlm.nih.gov/38335473/) |
| 1     | H3C3  | K28M     | Diffuse Midline Glioma, H3 K27-Altered | Dordaviprone (Level 1\)  | [FDA approval of dordaviprone](https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-dordaviprone-diffuse-midline-glioma); PMID: [38335473](https://pubmed.ncbi.nlm.nih.gov/38335473/) |
